ASM

415

-0.65%↓

UPM.FI

22.75

+1.74%↑

AKZA

54.68

+1%↑

STERV.FI

9.13

+1.67%↑

IDR

36.6

+1.5%↑

ASM

415

-0.65%↓

UPM.FI

22.75

+1.74%↑

AKZA

54.68

+1%↑

STERV.FI

9.13

+1.67%↑

IDR

36.6

+1.5%↑

ASM

415

-0.65%↓

UPM.FI

22.75

+1.74%↑

AKZA

54.68

+1%↑

STERV.FI

9.13

+1.67%↑

IDR

36.6

+1.5%↑

ASM

415

-0.65%↓

UPM.FI

22.75

+1.74%↑

AKZA

54.68

+1%↑

STERV.FI

9.13

+1.67%↑

IDR

36.6

+1.5%↑

ASM

415

-0.65%↓

UPM.FI

22.75

+1.74%↑

AKZA

54.68

+1%↑

STERV.FI

9.13

+1.67%↑

IDR

36.6

+1.5%↑

Search

KWS Saat SE

Uždarymo kaina

SektoriusPagrindinės medžiagos

62.3

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

61.3

Max

62.6

Pagrindiniai rodikliai

By Trading Economics

Pajamos

391M

313M

Pardavimai

759M

927M

P/E

Sektoriaus vid.

13.688

114.478

Pelnas, tenkantis vienai akcijai

9.62

Dividendų pajamingumas

1.52

Pelno marža

33.768

Darbuotojai

4,887

EBITDA

486M

403M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+18.12% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.52%

3.39%

Kitas uždarbis

2025-09-25

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

284M

2.2B

Ankstesnė atidarymo kaina

62.3

Ankstesnė uždarymo kaina

62.3

Naujienos nuotaikos

By Acuity

50%

50%

78 / 168 reitingas Basic materials

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bullish Evidence

KWS Saat SE Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-08-04 21:42; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

2025-08-04 21:21; UTC

Uždarbis
Pagrindinės rinkos jėgos

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

2025-08-04 20:45; UTC

Uždarbis

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

2025-08-04 19:15; UTC

Pagrindinės rinkos jėgos

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

2025-08-04 23:41; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-08-04 23:41; UTC

Rinkos pokalbiai

Nikkei May Rise on Fed Stimulus Hopes

2025-08-04 23:28; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-08-04 23:28; UTC

Rinkos pokalbiai

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

2025-08-04 21:30; UTC

Uždarbis

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

2025-08-04 21:21; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

2025-08-04 21:18; UTC

Uždarbis

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

2025-08-04 20:25; UTC

Rinkos pokalbiai

India Hits Back Over Russian Oil Purchases -- Market Talk

2025-08-04 20:25; UTC

Uždarbis

Transocean 2Q Loss $938M >RIG

2025-08-04 20:25; UTC

Uždarbis

Transocean 2Q Loss/Shr $1.06 >RIG

2025-08-04 20:18; UTC

Uždarbis

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

2025-08-04 20:15; UTC

Uždarbis

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

2025-08-04 20:14; UTC

Uždarbis

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

2025-08-04 20:14; UTC

Uždarbis

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

2025-08-04 20:14; UTC

Uždarbis

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

2025-08-04 20:13; UTC

Uždarbis

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

2025-08-04 20:09; UTC

Uždarbis

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

2025-08-04 20:06; UTC

Uždarbis

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

2025-08-04 20:01; UTC

Uždarbis

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

2025-08-04 20:01; UTC

Uždarbis

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

2025-08-04 20:01; UTC

Uždarbis

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

2025-08-04 20:01; UTC

Uždarbis

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

2025-08-04 19:41; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Settle Lower -- Market Talk

2025-08-04 19:28; UTC

Rinkos pokalbiai

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

2025-08-04 19:07; UTC

Rinkos pokalbiai

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

2025-08-04 18:27; UTC

Rinkos pokalbiai

Gold Climbs on Rate Cut Speculation -- Market Talk

Akcijų palyginimas

Kainos pokytis

KWS Saat SE Prognozė

Kainos tikslas

By TipRanks

18.12% į viršų

12 mėnesių prognozė

Vidutinis 73 EUR  18.12%

Aukščiausias 83 EUR

Žemiausias 66 EUR

Remiantis 5 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines KWS Saat SE kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

5 ratings

5

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

54.8 / 57.4Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bullish Evidence

Vidutinės trukmės periodas

Weak Bullish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

78 / 168 reitingas Pagrindinės medžiagos

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę KWS Saat SE

KWS SAAT SE & Co. KGaA breeds, produces, and distributes seeds for agriculture. It operates through four segments: Corn, Sugarbeet, Cereals, and Vegetables. The Corn segment breeds, produces, and distributes seed for corn, soybeans, and sunflowers. The Sugarbeet segment engages in the development, breeding, production, and development of diploid hybrid potatoes and sugar beet seeds. The Cereals segment breeds, produces, and distributes seeds for rye, wheat, barley, and oilseed rape. This segment also offers other crops, including peas, catch crops, and oats. The Vegetables segment engages in the breeding, production, and distribution of seeds for spinach, beans, Swiss chard, red beet, and tomatoes. The company was formerly known as KWS SAAT SE and changed its name to KWS SAAT SE & Co. KGaA in July 2019. KWS SAAT SE & Co. KGaA was founded in 1856 and is headquartered in Einbeck, Germany.